PLA2G4A and ovarian cancer: PLA2G4A encodes phospholipase A2, and quinacrine may inhibit ovarian cancer by inhibiting PLA2G4A which in turn reduces arachidonic acid metabolites and thus inhibits ovarian cancer development.